The China Mail - US panel weighs authorizing Covid vaccines for youngest children

USD -
AED 3.673042
AFN 72.000368
ALL 87.274775
AMD 390.940403
ANG 1.80229
AOA 912.000367
ARS 1137.970104
AUD 1.565349
AWG 1.8
AZN 1.70397
BAM 1.720686
BBD 2.017877
BDT 121.428069
BGN 1.721593
BHD 0.376901
BIF 2930
BMD 1
BND 1.312071
BOB 6.906563
BRL 5.808204
BSD 0.999437
BTN 85.314611
BWP 13.77569
BYN 3.270808
BYR 19600
BZD 2.007496
CAD 1.384165
CDF 2877.000362
CHF 0.81849
CLF 0.025203
CLP 967.160396
CNY 7.30391
CNH 7.30369
COP 4310
CRC 502.269848
CUC 1
CUP 26.5
CVE 97.403894
CZK 22.038604
DJF 177.720393
DKK 6.56557
DOP 60.503884
DZD 132.56604
EGP 51.126904
ERN 15
ETB 133.023649
EUR 0.879325
FJD 2.283704
FKP 0.752659
GBP 0.753835
GEL 2.740391
GGP 0.752659
GHS 15.56039
GIP 0.752659
GMD 71.503851
GNF 8655.503848
GTQ 7.698128
GYD 209.656701
HKD 7.763675
HNL 25.908819
HRK 6.612104
HTG 130.419482
HUF 359.10504
IDR 16862.9
ILS 3.68639
IMP 0.752659
INR 85.377504
IQD 1310
IRR 42125.000352
ISK 127.590386
JEP 0.752659
JMD 157.965583
JOD 0.709304
JPY 142.384504
KES 129.503801
KGS 87.233504
KHR 4015.00035
KMF 433.503794
KPW 899.999997
KRW 1418.390383
KWD 0.30663
KYD 0.832893
KZT 523.173564
LAK 21630.000349
LBP 89600.000349
LKR 298.915224
LRD 199.975039
LSL 18.856894
LTL 2.95274
LVL 0.60489
LYD 5.470381
MAD 9.275039
MDL 17.289555
MGA 4552.892736
MKD 54.091003
MMK 2099.344606
MNT 3566.297198
MOP 7.990393
MRU 39.435529
MUR 45.090378
MVR 15.403739
MWK 1736.000345
MXN 19.71941
MYR 4.407504
MZN 63.905039
NAD 18.856894
NGN 1604.703725
NIO 36.775056
NOK 10.47246
NPR 136.503202
NZD 1.67405
OMR 0.384998
PAB 0.999437
PEN 3.763039
PGK 4.133235
PHP 56.712504
PKR 280.603701
PLN 3.762405
PYG 7999.894426
QAR 3.640604
RON 4.378104
RSD 103.137317
RUB 82.174309
RWF 1415
SAR 3.752237
SBD 8.368347
SCR 14.241693
SDG 600.503676
SEK 9.62027
SGD 1.310745
SHP 0.785843
SLE 22.775038
SLL 20969.483762
SOS 571.503662
SRD 37.15037
STD 20697.981008
SVC 8.745073
SYP 13001.855093
SZL 18.820369
THB 33.347038
TJS 10.733754
TMT 3.5
TND 2.988038
TOP 2.342104
TRY 38.020804
TTD 6.781391
TWD 32.524038
TZS 2687.503631
UAH 41.417687
UGX 3663.55798
UYU 41.913007
UZS 12986.521678
VES 80.85863
VND 25870
VUV 120.966432
WST 2.777003
XAF 577.111964
XAG 0.03066
XAU 0.000301
XCD 2.70255
XDR 0.717698
XOF 575.000332
XPF 102.775037
YER 245.250363
ZAR 18.821904
ZMK 9001.203587
ZMW 28.458439
ZWL 321.999592
  • CMSD

    0.0400

    21.96

    +0.18%

  • JRI

    0.1600

    12.4

    +1.29%

  • BCC

    0.7800

    93.47

    +0.83%

  • BCE

    0.4200

    22.04

    +1.91%

  • SCS

    0.0500

    9.76

    +0.51%

  • NGG

    0.6300

    72.11

    +0.87%

  • GSK

    0.5600

    35.93

    +1.56%

  • RBGPF

    63.5900

    63.59

    +100%

  • CMSC

    0.0400

    21.82

    +0.18%

  • RIO

    1.0100

    58.17

    +1.74%

  • AZN

    0.5400

    67.59

    +0.8%

  • VOD

    0.1400

    9.31

    +1.5%

  • RELX

    1.0000

    52.2

    +1.92%

  • RYCEF

    -0.1400

    9.36

    -1.5%

  • BP

    0.6600

    28.32

    +2.33%

  • BTI

    0.5400

    42.37

    +1.27%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: © AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

C.Smith--ThChM